© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Eperisone Hydrochloride first entered medical circles in Japan in the early 1970s, part of a wave of non-benzodiazepine muscle relaxants. Interest in this compound grew out of frustration with drugs causing excessive sedation or dependence. Researchers working in Tokyo aimed to create a compound that would relieve muscle spasticity without draining a patient’s energy. The discovery of Eperisone’s unique muscle relaxant and vasodilatory properties placed it on a short list of drugs quickly moving from bench to bedside. Its approval across Asia reflected a need for muscle relaxants that offered both relief from spasticity and decent patient mobility, particularly among elderly populations and those recovering from strokes. Over the decades, clinics and hospitals from Seoul to Mumbai kept Eperisone on their shelves, recognizing that its balanced profile fit into the daily realities of managing chronic and acute muscle pain.
Eperisone Hydrochloride steps out from traditional antispasmodics with its smooth muscle and central nervous system activity. In practice, the compound often appears as colorless or white crystalline powder, throwing doctors for a loop who expect more obvious substances. Hospitals stock it as oral tablets and, less often, injectables. Dosages hover between 50mg to 150mg per day, split across two or three administrations depending on severity. Pharmacists appreciate that Eperisone sidesteps common problems tied to anticholinergic effects, like dry mouth and blurred vision, factors that drive compliance up in long-term therapy. Patients suffering from chronic low back pain or cervical spondylosis frequently reach for prescriptions containing this compound, citing better tolerance and fewer side concerns compared to earlier-generation relaxants.
Eperisone Hydrochloride holds a melting point near 174°C, coming in as a stable, odorless solid easily handled in routine lab and pharmacy environments. Its solubility in water and most common organic solvents means the active compound moves quickly into solution in the stomach, playing into its relatively swift onset of action. The molecular formula—C17H23NO·HCl—places it in the piperidine family, and the hydrochloride salt boosts stability, shelf-life, and patient absorption rates. Chemists, recalling their lab days, point out that the strength of its ionic bonds supports tablet manufacture, holding up well during storage in tropical climates.
Each batch, whether intended for tablets or compounded syrups, undergoes scrutiny for purity exceeding 98%, as demanded by strict pharmacopeia standards in Japan and India. Pharmaceutical firms stamp lot numbers and manufacturing dates on every label, and regulatory agencies enforce storage at controlled room temperature (15–30°C). Official labeling lists the active salt, standard excipients like microcrystalline cellulose, and advice to keep out of reach of children. Warnings on hypersensitivity reactions and careful use in patients with a history of hepatic impairment remain front and center, reflecting lessons picked up from thousands of prescriptions filled on busy hospital wards. Some manufacturers include QR codes linking to digital leaflets, responding to modern patient demands for transparency and traceable sourcing.
Production stems from a multi-step synthesis: chemists start with 4’-methylpropiophenone, launch a Grignard reaction to extend the molecule, and wrap up with cyclization steps to build the piperidine ring. Adding hydrochloric acid yields the stable hydrochloride salt. Each intermediate faces analytical checks using HPLC and mass spectrometry, with a keen eye toward residual solvents and unreacted by-products. Final drying processes remove moisture below 0.5%, ensuring tablet stability even in high-humidity storage. Major generics manufacturers in India, Japan, and Korea stick close to established process patents but implement upgraded filtration and purification systems, reducing process waste and securing consistent pill quality.
Eperisone’s piperidine and aromatic methoxy groups make the molecule surprisingly resistant to light and air. Scientists working on next-generation analogs modify the ring or swap out methoxy substituents in hopes of boosting muscle-relaxing potency or extending half-life. Some modifications target slow release, aiming for once-daily dosing to help patients who forget afternoon tablets. Other chemists toy with prodrug strategies to optimize absorption for sublingual or injectable formats, hoping to widen use beyond oral tablets. To date, most patents focus on refining the parent molecule’s solubility and taste, ensuring better patient compliance and reliable bioavailability across a wide range of metabolic profiles.
On international markets, Eperisone Hydrochloride goes by several names. In Japan, the name Myonal dominates. Indian generics turn up with monikers like Epry, Eprisan, and Epyhydro. Pharmacopoeias list the full name, but hospital staff often rely on brand shorthand for rapid communication at the bedside. Researchers sorting through clinical literature encounter nomenclature like 4’-ethyl-2-methyl-3-piperidinopropiophenone hydrochloride, but most doctors stick with the simple “Eperisone.”
Doctors prescribing Eperisone monitor patients for dizziness and allergic rashes, the most common side effects, usually minor but important to catch early in those with sensitive systems. Standard operating procedures instruct labs and pharmacy techs to glove up during handling, since trace skin absorption could cause mild CNS symptoms. The lack of sedative hangover compares favorably to muscle relaxants requiring restricted activity or driving bans. Regular audits track pharmacovigilance reports, especially with long-term use in chronic conditions, so adverse patterns get picked up before expanding. Educational programs in clinics keep prescribers updated with the latest regional safety data, reinforcing a cycle of caution and feedback.
Most prescriptions go to patients wrestling with muscle spasms, neck or lower back stiffness, post-stroke spasticity, and recovery from orthopedic injuries. Neurologists favor Eperisone for elderly patients who fail to tolerate benzodiazepines. In rehabilitation departments, the drug tags along with physical therapy to bring functional improvement to those who would otherwise struggle with movement. Some doctors experimenting with off-label use try it in migraine and tension headache, relying on its unique vasoactive features, though robust studies remain limited. Clinics in warmer, humid countries, using local generics, value the solid shelf stability and patient reliability even in clinics without air conditioning.
Ongoing research pushes for extended-release tablets, combination products with analgesics, and improved formulations suitable for pediatric and geriatric use. A recent multi-center study in Malaysia drew attention to differences in bioavailability among regional generic forms, a reminder that subtle tweaks in excipients shape patient outcomes. Academic centers continue to investigate how the compound modulates neural transmission at the spinal and supraspinal levels, with some focus now shifting to its anti-inflammatory potential in chronic pain syndromes. Collaborations between Japanese researchers and South Asian pharmaceutical developers seek to refine dosage protocols and deliver on big promises for Asia’s aging population.
Animal studies in the late twentieth century found a large safety window: acute toxicity appears only at doses far above the human clinical range. Chronic exposure data flags mild liver enzyme elevation in a subset of patients, so baseline and follow-up liver function tests now standardize the monitoring process. Reports of allergy and anaphylactic reactions remain rare but possible, justifying strict regulatory oversight. Human overdose cases typically show mild central nervous depression and hypotension, reversed in most cases with supportive care and withdrawal of the drug. No teratogenic effects appear in animal offspring with therapeutic exposure, but as a matter of prudence, medical guidelines steer clinicians away from use in early pregnancy.
The next era for Eperisone Hydrochloride centers on expanding its therapeutic reach while refining safety profiles. As pain management continues drifting away from opioid-heavy models, doctors expect a steady uptick in the use of multi-modal therapies, with Eperisone sitting firmly in the mix. Pharmaceutical companies invest in developing granule and patch formulations, looking to simplify administration for older adults with swallowing trouble. Digital tracking of patient outcomes, paired with AI-driven analytics, promises to unearth undiscovered patterns in side effects and optimal dosing. If new research confirms robust anti-inflammatory or neuroprotective effects, the compound may leap from a niche muscle relaxant to a core part of comprehensive pain relief protocols worldwide, particularly in regions hit hard by aging and chronic illness.
Doctors often reach for muscle relaxants to help ease pain caused by muscle stiffness, and Eperisone Hydrochloride stands out in this group. Going to a hospital with a stiff neck, back pain, or the kind of cramps that refuse to let up, many people walk out with a prescription for this particular medicine. Unlike painkillers, which only mask symptoms, Eperisone works by tackling the muscle tension itself, helping the muscles calm down without making you feel groggy or dazed.
Jobs keep people hunched over laptops for hours, and physical strain remains a regular problem for workers in factories or on farms. Over time, muscles start rebelling with spasms, headaches, or even numbness. Simple routines like standing up, stretching, or massaging sore spots offer help, but stubborn pain calls for extra support. Here’s where Eperisone makes a difference.
Unlike other muscle relaxants that leave people drowsy and unable to focus, Eperisone tends to be gentler on alertness. That speaks to my experience working shifts where staying sharp matters. Several of my colleagues who manage old sports injuries or stress-related muscle pain prefer Eperisone because they say they can finish their shifts, drive home, and still feel in control. It helps relieve stiffness and improve blood flow, which studies link to better healing for those with conditions like cervical spondylosis or lower back issues. Doctors in countries like Japan and India recommend this medicine for chronic pain that lingers despite rest and stretching.
Published clinical trials have shown that patients with neck or back pain recover faster when Eperisone is included in their plan. Peer-reviewed research, including findings in journals such as the International Journal of Neuroscience, points out improved range of motion and lower pain scores when patients stick with the routine. Not every medicine works for everyone, but the numbers back up Eperisone's benefit for many people stuck in pain loops.
No medicine comes without risk. A few people using Eperisone report mild headaches, stomach upset, or skin rash. Compared with other muscle relaxants, though, the risk of feeling mentally foggy drops a lot. Of course, anyone starting a new pill, especially older adults or people taking several medications, should talk with their doctor and keep an eye out for new symptoms.
Eperisone remains unfamiliar in many places where chronic muscle pain ruins sleep and limits work opportunities. A gap in both availability and clear information leaves patients guessing or settling for less effective treatment. Highlighting real-world stories, making up-to-date guidelines available to primary care doctors, and keeping prices reasonable could help more people benefit.
Muscle pain doesn't just keep people from their jobs; it eats away at relationships, sleep, and overall health. Medicines like Eperisone deserve more attention as part of a plan that includes movement, better posture, and mental health support. Real change begins with listening to pain, understanding options, and demanding reliable, affordable care. That can only happen if both providers and patients stay informed and speak up about what works.
Eperisone hydrochloride helps relieve muscle stiffness and spasms. You often see it prescribed for people dealing with neck and back pain or similar musculoskeletal pain, especially in East Asia. As with most muscle relaxants, you find both relief and room for concern from side effects that come up more often than people expect.
Many users battle dizziness and weakness not long after starting this medication. I’ve spoken to people who struggled to keep up with daily routines because the spinning feeling won’t go away for hours. Drug safety reports from Japan show that these issues pop up in about 3-5% of patients. Dizziness might seem minor, but for older adults or those commuting, it brings real risks for falls. Doctors always listen for these complaints because muscle relaxants, in general, mess with body coordination.
Nausea, vomiting, and an upset gut often follow the first few doses. If I think back on my own relatives recovering from slipped discs, I remember Eperisone hydrochloride did a number on their appetites too. Published studies in clinical journals estimate digestive side effects strike about one in every twenty patients. Though the gut issues usually ease up with time, folks dealing with stomach conditions or those who can’t afford to lose weight notice the impact more.
Many just feel worn out. The sedation effect can wash over you, making focus at work or home a daily struggle. This drowsiness, as I’ve seen in community clinics, sometimes drives people to cut their pills in half or skip a dose to keep their energy up. Unfortunately, that means pain relief also drops off, leaving folks stuck between tiredness and stiff muscles.
Reports point to occasional headaches and a jittery, shaky feeling soon after people start on Eperisone hydrochloride. While not as frequent as dizziness or stomach upset, this kind of side effect can feel alarming. The exact reason isn’t always clear, but people with anxiety or a history of migraines notice these symptoms show up more often.
Serious problems rarely pop up, but allergic reactions get attention in safety discussions. Rash, itching, or swelling may signal something bigger. In rare cases, people landed in emergency rooms after taking just a few doses. Spotting these early and getting medical advice can make a big difference. Blood pressure drops have also shown up in vulnerable groups, making close monitoring important for older people.
Mixing Eperisone hydrochloride with other muscle relaxants or sedatives invites more side effects. People with kidney or liver trouble might have trouble clearing the drug, raising the risk further. Age plays a role—older adults face more dizziness and blood pressure changes. That’s why many doctors start with the lowest possible dose.
For most, side effects settle down after a few days. Doctors often recommend starting after a meal, drinking more water, and skipping alcohol to keep problems in check. Community health workers point out the value of reporting symptoms early—don’t grit your teeth and hope it passes. A quick phone call or visit can help adjust the dose or switch to other options.
Eperisone Hydrochloride comes up in conversation mostly when someone can’t move their neck or their back decided to spasm just as they tried to lift groceries. My uncle tried Eperisone for neck stiffness after a minor fender bender. He picked it up at the pharmacy based on his doctor’s prescription. If you’ve ever faced those gnawing muscle cramps that disrupt sleep or work, you know why this medication finds a spot in the medicine cabinet.
Doctors don’t just hand out prescriptions for show. They’re trying to match a person’s medical history, lifestyle, the reason for the stiffness, possible other medicines, and more. I watched my uncle fumble with his pills, sometimes forgetting, sometimes doubling up. His doctor acted like a broken record: take one tablet after meals, don’t skip, don’t double up if you miss a dose, and report anything odd, like dizziness or nausea.
Getting that rhythm of three times a day after eating can feel like a hassle, especially with work shifts that don’t match a classic breakfast-lunch-dinner pattern. But food helps Eperisone settle in better and keeps the stomach from revolting. Some start feeling lighter or less tense, and the temptation is there to toss the rest of the tablets into the back of the cupboard. But it’s not a painkiller, so it doesn’t give instant relief. Muscles gradually relax over several days. Stopping early can bring the problem right back.
Back home, over-the-counter painkillers, muscle balms, and heat packs get handed out as soon as someone complains. Eperisone doesn’t belong in the home remedy bag. This medication works directly with nerves and blood vessels to relax specific groups of muscles. It shouldn’t get used just because someone’s sore from an extra gym session.
Misusing it brings real risk. Eperisone can mess with blood pressure, cause allergic reactions, or leave someone drowsy at the wheel. The elderly, people with liver disease, anyone using other sedatives or muscle relaxants — they especially need to check and check again before mixing medicines.
Every medicine has a risk. Eperisone may cause headache, stomach trouble, sleepiness, or even allergic reactions. One of my cousins ignored warnings and drove home from work, only to realize she couldn’t keep her eyes open halfway through. Experiences like that stick. Always pay attention during the early days of any new medicine.
Nobody knows your body better than you and your doctor working together. Before starting Eperisone, bring up allergies, current medications, and any problems with the liver or kidneys. Let the healthcare provider know exactly why you’re seeking muscle relief, whether from an injury, chronic back pain, or something else. There’s a reason professional advice stays crucial — it’s not just about avoiding dangerous combinations, but making sure you’re even using the right tool for the job.
Eperisone doesn’t replace gentle stretching, physical therapy, or learning which movements help rather than hurt your body over time. In my family, using the pill only worked alongside careful posture fixes, lighter lifting habits, and honest check-ins with medical staff. There’s no shortcut to healing, but the right guidance makes all the difference.
Eperisone hydrochloride sees use as a muscle relaxant, mainly for people struggling with painful muscle spasms. Doctors in several Asian and Eastern European countries write this prescription to help with neck pain, low back issues, or after certain orthopedic surgeries. The big question often comes up at the pharmacy window: is it okay for pregnant or breastfeeding women? Many expectant mothers struggle with muscle tension and look for relief, hoping for a safe answer.
Most of the answers remain tucked away in small print or buried in research papers. Right now, medical literature just does not lay down solid proof that eperisone is safe for mothers-to-be or infants drinking breast milk. Studies on pregnant animals show some possible risk, but nothing comprehensive draws the line for human safety. Drug monitoring agencies in places like India and Japan advise extra caution. The U.S. Food and Drug Administration does not list eperisone in its official pregnancy risk categories. No major Western guidelines endorse this drug for pregnant or nursing women.
I remember colleagues in hospital halls worrying about the unknown effects of many muscle relaxants. With eperisone, the silence in research makes that worry real. Every doctor knows stories of patients who nervously ask, “Will this medicine hurt my baby?” The doctor, searching through databases, finds no clear comfort—only murky answers and best guesses based on general principles.
Why bother with caution? In pregnancy, nearly every drug crosses the placenta in some amount. Unsuspecting damage might show up in development, birth weights, or neural growth. For breastfeeding, small drug molecules slip into milk, exposing newborns to even trace substances that no one has tested in tiny bodies. Most information on eperisone so far comes from studies tracking short-term adult side effects—sleepiness, dizzy spells, changes in blood pressure. Long-term effects or risks to babies just have not been studied on a useful scale.
Reports collected in Japan over decades focus mostly on adult reactions and rarely touch on pregnancy or breastfeeding. The little guidance out there suggests avoiding this drug for mothers unless absolutely necessary, and only if no safer alternative exists.
Doctors often look to safer, well-studied alternatives first. Acetaminophen usually stands as the painkiller of choice during pregnancy. Simple physical therapy, massage, and rest carry much less mystery. Some doctors use other muscle relaxants with more established safety records, but each comes with its own caution tape. Communication matters just as much as the right pill—a mother deserves to hear the truth, spelled out plainly.
The FDA calls for expanded pregnancy and lactation studies for every approved medication. Progress tends to move slowly, but the worldwide medical community cannot ignore this blind spot. Valuable data sometimes comes from post-marketing surveillance, voluntary reporting, and careful long-term studies of children whose mothers took new medications.
Anyone pregnant or nursing deserves a doctor who listens, checks the latest studies, and weighs benefits against risks. Clear conversations help cut through the fog of uncertainty. Women turning to eperisone should ask hard questions. If no strong studies back the drug’s safety, it makes sense to push for options that do. Researchers and regulators should update drug safety labels and share new findings as soon as science catches up. Until then, beware of easy promises, and remember that in medicine, new research can change decisions overnight.
Eperisone hydrochloride usually finds a place in prescriptions for muscle stiffness and pain. For folks relying on this medicine, questions naturally follow: can it cause problems with other treatments? Doctors and pharmacists encourage honest conversations about medicines because new drug combinations can mess with how each pill behaves. As someone who has watched family members manage multiple prescriptions, opening up about drug safety has real stakes beyond just theory.
Eperisone works on both muscles and the brain, so medicines that affect the nervous system deserve special attention. Taking eperisone with other muscle relaxants, for instance, ramps up the risk of dizziness, drowsiness, and even a dangerous drop in reflexes. Some folks have combined it with benzodiazepines like diazepam or sleep medicines, only to discover that simple activities became much harder. Tasks that need focus or good coordination can quickly turn unsafe.
Many people with pain issues use painkillers like NSAIDs or, less often, opioids. While eperisone doesn't always directly clash with those drugs, stacking too many “downer” medicines raises the chance of slow breathing or falls. Older adults deserve extra caution, since recovery from falls gets tougher as we age.
Medications that change liver activity lead to a whole new set of worries. Eperisone clears out of the body using liver enzymes. Certain drugs, like some epilepsy medications—think phenytoin or carbamazepine—rev up the liver, pushing eperisone out too fast and reducing its benefit. On the other hand, antibiotics like erythromycin or some antifungals slow things down, which can make eperisone pile up in the body. Too much eperisone, and side effects like headache, weakness, and stomach trouble soon follow.
Beyond that, blood-pressure medications deserve mention. Eperisone itself lowers blood pressure as a side effect. Mix it with antihypertensives, and blood pressure can dip too much. People have described feeling faint, especially after standing up quickly; for some, it leads right to the floor. That scenario causes anxiety and more doctor visits, adding stress that most people could do without.
Plenty of people keep quiet about supplements or herbal teas they drink to fight soreness or anxiety. These natural remedies sometimes speed up or slow down medications, too. Even grapefruit juice, famous for messing with liver enzymes, earns a warning in any honest discussion around drug safety. A casual attitude about these things has landed more than one friend in the emergency room unexpectedly.
Doctors check your medication list for a reason. If any symptoms change or worsen, writing it off as “just getting older” ignores possible drug reactions. Pharmacists serve as a valuable safety net for catching interactions. Most importantly, patients sharing accurate details about everything they take — prescriptions, over-the-counter drugs, teas, and vitamins — gives the care team a fighting chance to prevent avoidable problems.
No one can know every drug interaction off the top of their head. People staying upfront about their medicines, asking pharmacists for a second opinion, and checking in before adding something new keeps everyone safer. It's not just about protecting health — it's about saving time, money, and stress. Staying proactive turns a simple muscle relaxant into a manageable part of daily life, rather than a risk waiting to happen.
| Names | |
| Preferred IUPAC name | (2RS)-1-(4-ethylphenyl)-2-methyl-3-(1-piperidyl)propan-1-one hydrochloride |
| Other names |
Myonal Eperison Myodura Epry Epasol Epreson |
| Pronunciation | /ɛˈpɛrɪˌsoʊn haɪˈdrɒklaɪd/ |
| Identifiers | |
| CAS Number | 56839-43-1 |
| Beilstein Reference | 3852963 |
| ChEBI | CHEBI:31449 |
| ChEMBL | CHEMBL2104805 |
| ChemSpider | 21573097 |
| DrugBank | DB12461 |
| ECHA InfoCard | 100.108.320 |
| EC Number | 87440-60-8 |
| Gmelin Reference | 61551 |
| KEGG | D07973 |
| MeSH | D017207 |
| PubChem CID | 6918495 |
| RTECS number | SY8570000 |
| UNII | 12SX9J189R |
| UN number | UN3077 |
| CompTox Dashboard (EPA) | DTXSID4014295 |
| Properties | |
| Chemical formula | C17H26ClNO |
| Molar mass | 291.82 g/mol |
| Appearance | White or almost white crystalline powder |
| Odor | Odorless |
| Density | 1.2 g/cm³ |
| Solubility in water | Freely soluble in water |
| log P | 2.6 |
| Acidity (pKa) | 8.42 |
| Basicity (pKb) | 7.46 |
| Magnetic susceptibility (χ) | -64.0e-6 cm³/mol |
| Refractive index (nD) | 1.657 |
| Dipole moment | 2.73 D |
| Thermochemistry | |
| Std enthalpy of combustion (ΔcH⦵298) | -6200 kJ/mol |
| Pharmacology | |
| ATC code | M03BX09 |
| Hazards | |
| Main hazards | May cause drowsiness, dizziness, gastrointestinal disturbances, allergic reactions, or hypotension. |
| GHS labelling | GHS02,GHS07 |
| Pictograms | `ATC code: M03BX09 | DrugBank: DB12446 | PubChem: 6918185 | ChemSpider: 5293691 | UNII: 1W4A651I38 | KEGG: D04161 | ChEBI: 135700 | ChEMBL: CHEMBL2107057` |
| Signal word | Warning |
| Hazard statements | H302: Harmful if swallowed. H315: Causes skin irritation. H319: Causes serious eye irritation. H335: May cause respiratory irritation. |
| Precautionary statements | Keep out of reach of children. Store in a cool and dry place. Protect from light and moisture. Use only as directed by the physician. Do not exceed the recommended dosage. If you experience any unusual symptoms, seek medical advice promptly. |
| Flash point | Flash point: 230.3°C |
| Lethal dose or concentration | Rat oral LD50: 570 mg/kg |
| LD50 (median dose) | Mouse oral LD50: 150 mg/kg |
| NIOSH | DF0222990K |
| PEL (Permissible) | Not Established |
| REL (Recommended) | 50 mg orally 3 times daily |
| IDLH (Immediate danger) | Not established |
| Related compounds | |
| Related compounds |
Tolperisone Inaperisone Lanperisone Silperisone Floperisone |
